Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.
Philo Ventures (Lehi, UT) launches its $3M Sandbox Fund to back Utah student founders, providing pre-seed capital, mentorship, and early traction support, aiming to retain talent and strengthen the state’s innovation ecosystem.
Salt Lake City’s Power District breaks ground with Rocky Mountain Power’s 10-story HQ, signaling major westside redevelopment and a new mixed-use hub linking downtown, the airport, and Utah’s innovation economy.
Vector (Draper, UT), led by former Army aviator Andy Yakulis, secures a multi-million SOCOM contract, providing attritable drones via a subscription “Modern Warfare as a Service” model, with fiber-optic FPV integration, tactical training, and battlefield innovation showcased at the 47G Summit.
Element Ventures welcomes Sam Andersen as Investment Partner. Andersen will drive early-stage investments in Utah, building on the firm’s decade-long track record supporting successful startups across tech sectors.
Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.
EY Entrepreneur Of The Year John Lippert founded Scientia Vascular to create purpose-built neurovascular devices that reduce stroke treatment times by 30 minutes. His microfabricated guidewires and catheters are transforming brain surgery with unprecedented precision.
Utah’s SEDI Summit (UVU - Orem, UT) explored state-endorsed digital identity, emphasizing governance, privacy, and security. Leaders and legislators discussed technical frameworks, policy strategies, and human impacts, charting a roadmap for safe, equitable digital identity systems.
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.
